No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BSX240719P80000
- 3.80
- +0.40+11.76%
15min DelayTrading Jul 8 10:43 ET
3.80High3.80Low
3.80Open3.40Pre Close1 Volume164 Open Interest80.00Strike Price380.00Turnover18.18%IV-0.02%PremiumJul 19, 2024Expiry Date3.82Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9518Delta0.0813Gamma20.05Leverage Ratio-0.0060Theta-0.0069Rho-19.08Eff Leverage0.0122Vega
Intraday
- 5D
- Daily
News
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,900 Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 8.59% on an annualized basis producing an average annual return of 19.49%. Currently, Boston Scientific has a market
Pulse Stock Rallies 22% on FDA Breakthrough Designation
Global Deep Brain Stimulation Market Report 2024-2029 - Boston Scientific, Medtronic and Abbott Continue Their Market Dominance - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Deep Brain Stimulation Market: Analysis by Product, Application, End Use, Region Size, Trends and Forecast up to 2029" report has been added to ResearchAndMarkets.
Boston Scientific to Present Key Data at the 2024 American Society of Pain & Neuroscience Conference
MARLBOROUGH, Mass., July 8, 2024 -- Boston Scientific Corporation (NYSE: BSX) today announced the company's clinical data will be featured at the sixth annual American Society of Pain & Neuroscience (
Artisan Global Discovery Fund Trimmed Boston Scientific Corporation (BSX) for Valuation Discipline
Boston Scientific(BSX.US) Officer Sells US$539.79K in Common Stock
$Boston Scientific(BSX.US)$ Officer Carruthers Wendy sold 6,983 shares of common stock on Jul 1, 2024 at an average price of $77.3 for a total value of $539.79K.Source: Announcement What is statement
Comments
$Boston Scientific(BSX.US$
Boston Scientific To Acquire Silk Road Medical For $1.16B In Cash, Offering $44 Per Share; 30% Premium Over Last Closing Price; Deal To Enhance Neurovascular Portfolio And Close By Q4 2024 Pending Regulatory Approvals
Boston Scientific To Acquire Silk Road Medical For $1.16B In Cash, Offering $44 Per Share; 30% Premium Over Last Closing Price; Deal To Enhance Neurovascular Portfolio And Close By Q4 2024 Pending Regulatory Approvals
1
$Boston Scientific(BSX.US$
NEWS
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
Positive
MODULAR ATP study met all safety and efficacy endpoints.
Major complication-free rate of 97.5% for EMPOWER LP.
Communication success rate of 98.8% between EMBLEM S-ICD and EMPOWER LP.
ATP success rate of 61.3% with no patient therapy deactivations due to discomfort.
Pacing capture thresholds met in 97.4% of patients.
Positive clinical performance suggests a potential upgrad...
NEWS
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
Positive
MODULAR ATP study met all safety and efficacy endpoints.
Major complication-free rate of 97.5% for EMPOWER LP.
Communication success rate of 98.8% between EMBLEM S-ICD and EMPOWER LP.
ATP success rate of 61.3% with no patient therapy deactivations due to discomfort.
Pacing capture thresholds met in 97.4% of patients.
Positive clinical performance suggests a potential upgrad...
ColumnsOptions Market Statistics: Tesla Stock Jumps on Accelerated Production Plans Despite Earnings Miss
News Highlights
$Tesla(TSLA.US$ shares rose by 1.85%, closing at $144.68. Its options trading volume was 1.75 million. Call contracts account for 44.8% of the total trading volume. The most traded calls are contracts of $160 strike price that expire on Apr. 26th. The total volume reaches 48,736 with an open interest of 28,774. The most traded puts are contracts of a $140 strike price that expires o...
$Tesla(TSLA.US$ shares rose by 1.85%, closing at $144.68. Its options trading volume was 1.75 million. Call contracts account for 44.8% of the total trading volume. The most traded calls are contracts of $160 strike price that expire on Apr. 26th. The total volume reaches 48,736 with an open interest of 28,774. The most traded puts are contracts of a $140 strike price that expires o...
25
3
Insiders selling Boston Scientific shares, even below current price, is discouraging. Yet, high insider ownership could imply company's interest in all shareholders.
1
Boston Scientific's high P/E ratio is attributed to investors' optimism about its strong future growth and market outperformance. Shareholders' confidence in the company's future earnings supports the current P/E ratio and share price.
1
Read more